Department of Urology Archive — Page 5 of 9
-
August 26, 2020
Chang named Vanderbilt-Ingram Cancer Center chief surgical officer
Sam Chang, MD, MBA, has been named chief surgical officer at Vanderbilt-Ingram Cancer Center (VICC), a new leadership position responsible for advancing excellence in surgical care in cancer patients, expanding service locations, maximizing resource efficiencies and maintaining high-quality standards among other duties. -
July 15, 2020
Two brushes with death. Two life-saving Vanderbilt physicians. Then, two children.
"Vanderbilt will always be a place that we hold dear for everything they have done for us,” says Mary Beth Ballard Murray. -
July 9, 2020
Recurrent UTIs linked to hidden reservoir
Bacterial invasion of vaginal cells sets up a protective niche and a reservoir for recurrent urinary tract infections, Vanderbilt researchers demonstrated. -
May 27, 2020
Collaborative project from VU and VUMC improves intubation box safety for COVID-19 caregivers
As hospital and health care staff across the country continue learning more about the transmission and spread of COVID-19, caregivers for coronavirus patients continue adapting to the changing needs and best practices for personal protective equipment (PPE). -
April 23, 2020
Urologist Dmochowski named ABU president
The American Board of Urology (ABU) is naming Roger Dmochowski, MD, MMHC, professor, Department of Urologic Surgery, and associate surgeon-in-chief at Vanderbilt University Medical Center, as its president for 2020-2021. -
April 2, 2020
Physicians, engineering students, families and friends construct DIY face shields
As the number of COVID-19 infections continues to grow, Nashville resident Kobie Pretorius was searching for some way to provide meaningful help to others. And she realized her apprehension was spiking each morning as her husband went out the door for work. -
March 23, 2020
Study reveals an inherited origin of prostate cancer in families
Vanderbilt researchers have identified haplotypes, ancestral fragments of DNA, that are associated with hereditary prostate cancer (HPC) in a first-of-its-kind genomic study made possible by the study of prostate cancer patients with family histories of the disease.